Please enable JavaScript to view this website.
Skip to main content
Log in
Our Industry
Who We Are
Resources
The Value of Medicines Awards
Member Login
Home
Resources
Resources
Publications
See All
IQVIA Access to Medicines (AtoM 4) Report 2011 - 2023
20.09.2023
Read more
New Zealand's Medicines Landscape 2022/23
26.05.2023
Read more
PhRMA: Global Access to New Medicines Report
26.05.2023
Read more
Pharmac's Medicines Waiting Lists: Impacts on Patients in Aotearoa New Zealand
26.04.2023
Read more
New Zealand's Medicines Landscape 2021/22
23.05.2022
Read more
Whitepaper: Impact of Living with a Rare Disorder in Aotearoa New Zealand
28.02.2022
Read more
Key Findings of a National Omnibus Survey - Perceptive January 2022
31.01.2022
Read more
IQVIA Access to Medicines (AtoM 3) Report 2011-2020
01.12.2021
Read more
Media Releases
See All
Medicines New Zealand Publishes 2022 Transfer of Value Reports, Reinforcing Commitment to Transparency in the Biopharmaceutical Industry
25.08.2023
Read more
Medicines New Zealand congratulates Dr Peter Jansen on his new HQSC role and welcomes new Independent Chair, Mr Todd Krieble
22.05.2023
Read more
Medicines New Zealand is pleased to announce a new Independent Chair and a Te Ao Māori Director
30.01.2023
Read more
Medicines New Zealand Award recipient to develop novel biological ingredients into a tool that enhances patient healing and recovery after surgery.
17.11.2022
Read more
PHARMAC Review: A step in the right direction, but 'devil will be in the detail' for Government on actions to be taken
01.06.2022
Read more
Budget 2022 Medicines Investment: A start, but also a potential rapid and painful stop?
19.05.2022
Read more
Medicines Sector Actively Responds to the Ukraine Crisis in Europe
07.03.2022
Read more
Trans-Tasman Medicines Report: New Zealand Appalling Inequity Gap Exposed
20.12.2021
Read more
Submissions
See All
Pharmac Consultation: Paediatric cancer treatments in NZ
27.03.2023
Read more
Submission on the Therapeutic Products Bill
05.03.2023
Read more
Submission on Budget Policy Statement 2023
27.01.2023
Read more
Submission on Manatu Hauora LTIB Precision Health Consultation
27.01.2023
Read more
Medsafe Consultation: Proposed change to enable a labelling transition period when medicines are classified as a controlled drug or have a change to their controlled drug classification
27.01.2023
Read more
Submission to the Health Select Committee on the Medicines Amendment Bill (No 2)
10.06.2022
Read more
Submission to the Foreign Affairs, Defence and Trade Committee on the International treaty examination of the UK-NZ Free Trade Agreement
13.03.2022
Read more
Submission to the Education and Workforce Committee on the Accident Compensation (Maternal Birth Injury and Other Matters) Amendment Bill
11.02.2022
Read more